36C24E20Q0184.docx
DOCX document 13 KB Posted
- Attached to
- 6640--541-20-3-2021-0565 Capadona-Nanostrings (VA-20-00056035) (VA-20-00056035) Cleveland VA
- Solicitation number
- 36C24E20Q0184
About this file
This special notice from the Department of Veterans Affairs Veterans Health Administration Regional Procurement Office East describes a sole source procurement of a nCounter MAX Analysis System and a GeoMx DSP Analysis Instrument from NanoString Technologies Inc. The equipment will be used together at the Cleveland VA Medical Center Research and Development Group to support ongoing research projects analyzing gene expression and protein content in tissue samples. Interested parties believing they can meet the requirements as the original equipment manufacturer, authorized dealer, distributor or reseller may submit a capability statement by July 3, 2020 to Elaine DiBucci. A determination not to compete the proposed requirement will be at the Government's discretion based on the responses received.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Contract Opportunity Special Notice
PRODUCT SERVICE CODE
SUBJECT
CONTRACTING OFFICE'S
ZIP-CODE
SOLICITATION NUMBER
ARCHIVE
DAYS AFTER THE RESPONSE DATE
RECOVERY ACT FUNDS
NAICS CODE
CONTRACTING OFFICE
ADDRESS
POINT OF CONTACT
(POC Information Automatically Filled from User Profile Unless Entered)
DESCRIPTION
See Attachment
AGENCY'S URL
URL DESCRIPTION
AGENCY CONTACT'S EMAIL
ADDRESS
EMAIL DESCRIPTION
GENERAL INFORMATION
ADDITIONAL INFORMATION
* = Required Field Contract Opportunity Special Notice 541-20-3-2021-0565 Capadona-Nanostrings (VA-20-00056035)
(VA-20-00056035)
Cleveland VA 15212-5319 36C24E20Q0184 N 334516 US Department of Veterans Affairs Veterans Health Administration Regional Procurement Office (RPO) East 323 North Shore Drive, Suite 500 Pittsburgh PA 15212-5319 The Veterans Administration Cleveland VA Medical Center, Research and Development Group intends to negotiate on a sole source basis with NanoString Technologies Inc. for a nCounter MAX Analysis System and a GeoMx DSP Analysis Instrument. These two pieces of equipment will be utilized together to continue to support research projects currently being conducted at the Cleveland VA. The GeoMx DSP system allows for spatially resolved imaging and quantitative expression of mRNA and pre-validated protein content specific to neuroscience (and other applications) from FFPE or fresh/frozen tissue with optional readout on a next generation sequencer for quantification. While the nCounter allows for bulk gene expression (dissociating tissue) without the need of amplification that allows for up to 800 genes (custom or neuroscience/ neuroinflammation specific panels) assayed per sample. The nCounter also acts as the readout for the DSP system. Additionally, the nCounter MAX Analysis System must be an FDA-approved technology. This notice of intent is not a request for competitive proposals; however, any responsible source who believes it is capable of meeting the requirement and who is the Original Equipment Manufacturer (OEM), authorized dealer, authorized distributor or authorized reseller of all the items listed above, may submit a capability statement to the contracting office to the contracting office no later than Friday, July 3, 2020, 4:00 PM EST. Interest/capability statements may be sent to Elaine DiBucci at elaine.dibucci@va.gov. No telephone responses will be accepted. A determination not to compete the proposed requirement based upon the responses to this notice is solely within the discretion of the Government.
File details come from the government source that posted it. Updated .